When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Cholangiocarcinoma

Last reviewed: 27 Nov 2025
Last updated: 11 Nov 2025

Summary

Definition

History and exam

Key diagnostic factors

  • painless jaundice
  • weight loss
  • abdominal pain
Full details

Other diagnostic factors

  • pruritus
  • triad of fever, jaundice, and right upper quadrant pain
  • palpable gallbladder
  • hepatomegaly
  • dark urine
  • pale stools
  • asymptomatic
Full details

Risk factors

  • age >50 years
  • cholangitis
  • choledocholithiasis
  • cholecystolithiasis
  • other structural disorders of the biliary tract
  • ulcerative colitis (UC)
  • primary sclerosing cholangitis (PSC)
  • nonspecific cirrhosis
  • alcoholic liver disease
  • liver fluke infection
  • chronic typhoid carrier
  • hepatitis C virus (HCV)
  • HIV
  • hepatitis B virus (HBV)
  • exposure to thorium dioxide
  • diabetes
  • cigarette smoking
  • exposure to toxins/medications
  • male sex
Full details

Diagnostic tests

1st tests to order

  • serum bilirubin
  • serum alkaline phosphatase
  • serum gamma-GT
  • serum aminotransferase
  • serum prothrombin time
  • serum CA 19-9
  • serum carcinoembryonic antigen (CEA)
  • serum CA-125
  • abdominal ultrasound
  • abdominal CT
  • abdominal MRI
Full details

Tests to consider

  • endoscopic ultrasound (EUS)
  • MR angiography
  • ERCP
  • MRCP
  • percutaneous transhepatic catheterization (PTC)
  • positron emission tomography (PET)
  • Immunostaining
Full details

Emerging tests

  • optical coherence tomography (OCT)
  • peroral cholangioscopy
  • duodenoscope-assisted cholangioscopy

Treatment algorithm

ACUTE

resectable disease

unresectable disease

Contributors

Authors

N. Joseph Espat, MD, MS, FACS

Chairman of Surgery

Professor

Director Cancer Center

Department of Surgery

Roger Williams Medical Center

Boston University School of Medicine

Providence

RI

Disclosures

NJE declares he has no competing interests.

Ponnandai Somasundar, MD, MPH, FACS

Associate Professor and Chief of Surgical Oncology

Department of Surgery

Roger Williams Medical Center

Boston University School of Medicine

Providence

RI

Disclosures

PS declares that he has no competing interests.

Acknowledgements

We would like to acknowledge our Gastroenterology expert panel member, Dr Brooks Cash, for his contribution to this topic.

Disclosures

BC declares that he has no competing interests.

Peer reviewers

Kevin Watkins, MD

Assistant Professor

Department of Surgery

Health Science Center

SUNY

Stony Brook

NY

Disclosures

KW declares that he has no competing interests.

Savio Reddymasu, MD

GI Fellow

Department of Medicine

Center for Gastrointestinal Motility

Division of Gastroenterology and Hepatology

University of Kansas Medical Center

Kansas City

KS

Divulgaciones

SR declares that he has no competing interests.

Satvinder Mudan, MBBS, BSc, MD, FRCS

Consultant in Surgical Oncology

The Royal Marsden Hospital

London

UK

Divulgaciones

SM declares that he has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268-1289.Texto completo  Resumen

Bowlus CL, Arrivé L, Bergquist A, et al. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology. 2023 Feb 1;77(2):659-702.Texto completo  Resumen

Rushbrook SM, Kendall TJ, Zen Y, et al. British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma. Gut. 2023 Dec 7;73(1):16-46.Texto completo  Resumen

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: biliary tract cancers [internet publication].Texto completo

Shroff RT, Kennedy EB, Bachini M, et al. Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline. J Clin Oncol. 2019 Apr 20;37(12):1015-1027.Texto completo  Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Cholangiocarcinoma images
  • Diferenciales

    • Hepatocellular carcinoma (HCC)
    • Ampullary carcinoma
    • Pancreatic carcinoma
    Más Diferenciales
  • Guías de práctica clínica

    • NCCN clinical practice guidelines in oncology: biliary tract cancers
    • ACR-ABS-ACNM-ARS-SIR-SNMMI practice parameter for radioembolization of liver malignancies
    Más Guías de práctica clínica
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad